VANCOUVER, BC — Newsfile Corp. — NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of… Read More
VANCOUVER, BC–(BUSINESS WIRE)–STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have announced that they have signed an agreement for the use of tissue-derived organoids—including lung, intestinal, and liver organoids—for use in… Read More
VANCOUVER, BC and RIDGEWOOD, N.J., — PRNewswire — Aequus Pharmaceuticals Inc. (TSX-V: AQS) (OTCQB: AQSZF) (“Aequus”) and reVision Therapeutics, Inc. (“reVision”) announce a collaboration on the development of a therapy for Stargardt… Read More
– Assets expand immunology portfolio to include B-cell therapy (BAFF/APRIL) and macrophage modulation – – IND-enabling studies are ongoing and will support the transition of these assets to clinical development… Read More
The B.C. government is investing nearly $25 million to support 34 post-secondary research projects that will drive innovation and economic growth. The projects will also help create jobs, protect biodiversity… Read More
